AQST logo
Aquestive Therapeutics, Inc.(AQST)
Last print unknown agoAbout this dataData status
$3.83▲0.05 (1.32%)Stale · unknown old

AQST SBC to Revenue

17.32%TTM

Retrieved:

AQST FY SBC/Revenue%
AQST FY SBC/Revenue49.73%-5.33%
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

AQST sbc to revenue history

Stock-based compensation as percentage of revenue. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Aquestive Therapeutics Inc SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
17.1153%
12.333%
5.316%
9.1883%
13.4148%
14.3536%
13.4407%
44.4016%
0%
0%

Compare sbc to revenue

All AQST financial metrics · AQST stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.